- [Instructor] At its
most simplistic level, regulation of metabolic pathways inside of the body is really just a fancy word for a balancing act that's
occurring in the body. So, to illustrate this, I have a seesaw and we've been learning
about two metabolic pathways: glycolysis, which is the
process of breaking down glucose into pyruvate;
and gluconeogenesis, which is essentially the
opposite in which we start out with pyruvate and through a little bit of a different route we
end up back at glucose. And when we're talking about
the regulation of these particular pathways, we're
essentially asking ourself, "When is glycolysis
the predominant pathway and when is gluconeogenesis
the predominant pathway?" The body wants to make sure
that we either have a net breakdown of glucose, in
the case of glycolysis, or that we have a net
production of glucose, in the case of gluconeogenesis. So now the next question
is, "How does the body "accomplish this balancing act?" And to answer this question,
the way I like to think about it is to think
about it along a spectrum. There are very fast-acting
forms of regulation that take place on the order of seconds, and there are very very
slow forms of regulation that can take up to hours
or even days to occur. So let's talk about each of these in a little bit more detail. The major principle that helps
me understand fast-acting forms of regulation is
a good old principle from general chemistry:
Le Chatelier's Principle. So if you remember, Le
Chatelier's Principle talks about anything that's in equilibrium and it says that if there's
any change to this equilibrium, let's say more products are added or reactants are taken away,
the equilibrium will adjust to essentially counter that change and return the system back to equilibrium. So what does this mean in the
context of metabolic pathways like glycolysis and gluconeogenesis? So let's remind ourselves
that in glycolysis, glucose is converted to pyruvate
through several reactions that are all in equilibrium
with one another, and so we can essentially think about this metabolic pathway as a
series of equilibria. And so imagine, for example, if we had an influx of glucose, let's say
we've just eaten a big meal, and a huge bunch of glucose has entered our body and our blood stream. What will happen to this equilibrium? Well, we can return to
Le Chatelier's Principle and say that if we have a rise in glucose, it will essentially push
this entire equilibria towards the production of pyruvate. And so you can see that in this example, Le Chatelier's Principle
allows this equilibrium to adjust within seconds to just a simple influx of glucose
to promote glycolysis. Le Chatelier's Principle also
applies to gluconeogenesis. So remember that in gluconeogenesis, something unique starts to
happen after blood glucose levels have been low for a while. Amino acids being to break
down and form this metabolite called oxaloacetate, and
remember that oxaloacetate plays its unique role in
its conversion of pyruvate back to glucose which
occurs in gluconeogenesis. Remember that it's kind
of this intermediary. So pyruvate is converted to oxaloacetate and then essentially reenters the equilibria to form glucose. So you can imagine that if we have an influx of oxaloacetate,
the equilibria will be pushed towards the opposite
direction, that is, towards the production of glucose. Now in addition, I wanna
briefly mention another form of fast-acting regulation, which is call allosteric regulation. So what is allosteric regulation? Recall that all metabolic
pathways have unique enzymes that catalyze or facilitate each step of the reactions along
the metabolic pathways. So you can imagine that
if we have an enzyme here, I'm just drawing a simple structure, it has what's called an active site, where it actually binds
the substrate of interest so it binds the, let's
say, glucose molecule here, but in addition there are
also molecules within a cell that we call allosteric
regulators and these, by definition, bind to
a portion of the enzyme that is not the active site. So let's say we have an
allosteric molecule that binds to a separate portion like right here. Now this allosteric molecule
can have one of two effects. We say that allosteric
molecules can be inhibitory, that is, by inhibiting
enzymes, inhibit the pathway that utilizes those
enzymes, or these allosteric interactions can be positive, that is, promote the action of
enzymes and therefore promote the overall reaction in which
those enzymes are involved. So to put this in context with glycolysis and gluconeogenesis above,
it turns out that ATP is actually a big allosteric regulator of one of these two pathways. So recall that
gluconeogenesis requires ATP, a net amount of ATP, to produce glucose. It's an anabolic building up pathway. On the other hand, in glycolysis, there is a net release of ATP and the
oxidative breakdown of glucose. And so we have a lot of ATP in a cell, think about, for a moment, which of these two pathways would be favored. Indeed, gluconeogenesis would probably be favored because it requires ATP. On the other hand, if
there's a lot of ATP, that's kind of a sign to the cell to say, "Hey, we don't need to
perform as much glycolysis "because we already have
enough ATP available." And it does turn out that
ATP is actually an allosteric regulator of a couple
enzymes in glycolysis. And specifically, it's a
negative allosteric regulator, or an inhibitor, of these couple enzymes. Essentially it's putting
the breaks on glycolysis and saying, "We have enough energy "and we don't need to produce any more." On the other hand, it turns
out that there is also a molecule, AMP, in the body which is basically a sign that the cell has used up all
of its ATP, in other words, ATP has been dephosphorylated, and turned into AMP which is a sign that that
cell is running out of ATP. So if the cell is running
out of ATP, the cell probably won't want to be
performing energy-requiring processes such as
gluconeogenesis, and indeed, AMP is a negative allosteric regulator of one of the enzymes in gluconeogenesis. Alright, so that kind of
finishes up our discussion of fast-acting forms of regulation. So now let's talk
briefly about slow-acting forms of regulation. So these types of regulation
often take advantage of transcriptional
changes within the cell. So what do I mean by that? So let's first remind ourselves
what transcription is. So remember that
transcription is a process of taking DNA and making
an mRNA transcript and then translating this
in the cytosol of the cell to a protein product and when
we're talking about proteins oftentimes we're talking about enzymes. So I'm just gonna go write that here since it's relevant for our discussion. And so you can imagine
for example that this might be very useful if the organism is in a longterm fasting state. It will want to essentially
up-regulate the transcription of enzymes that promote
something like gluconeogenesis so that it can dump
glucose into the blood. And notice here that even
visually as it's implied here this process of going from
DNA to mRNA to enzymes is going to take much longer
than a simple Le Chatelier or allosteric regulation and
so that's why this process is more of an adaptive process
that allows the organism to adapt to more of long term changes that it experiences in its environment. Now finally I want to add in
one more form of regulation between fast- and slow-acting regulation which is called hormonal regulation. So what is hormonal regulation? Well it's exactly what it sounds like. It's the ability for the
body to essentially produce specific hormones which
are simply molecules that travel in the blood to
regulate whether glycolysis or gluconeogenesis is on or off. And the two hormones that
the body uses to regulate glycolysis and gluconeogenesis
and pretty much, actually, all metabolic pathways, are insulin and another hormone called glucagon. And depending on whether
there is more insulin or more glucagon, the
body will be more likely to do glycolysis or more
likely to do gluconeogenesis. So let's talk about how
that decision is made. Now hormones, like insulin
and glucagon, are usually released by the body whenever the body deviates from a particular set point. Now in the case of
regulation of metabolism, the set point that we're interested in is the blood glucose
level, and if we return back to our analogy
here, this seesaw here, this pivot point we can
think about as our set point. The blood glucose level:
it's a specific amount of glucose that the body wants to have in the blood at all times. Now to get more specific, if
the blood glucose level rises it actually stimulates the body to release the hormone insulin, and if the blood glucose levels decrease, it stimulates the body to
release the hormone glucagon. And so with that in mind,
take a moment to think about which hormone, insulin or glucagon, promotes glycolysis, and which of these two hormones promotes gluconeogenesis. Basically this is actually
a macro-application of Le Chatelier's Prinicple, right? If we have too much blood glucose level, we want to get rid of it. How do we get rid of it? We break it down. And so indeed, insulin
promotes glycolysis. On the other hand, when
blood glucose levels are low, we want to return the
equilibrium to normal, we want to pump more
glucose back into the blood and we know that gluconeogenesis
can accomplish that for us. And so glucagon indeed
promotes gluconeogenesis. Now briefly at the end I want
to talk about why I decided to put hormonal changes between fast- and slow-acting forms of regulation. So to talk about this, we need
to understand a little bit how hormones interact with target cells. So cells in our body
have particular receptors that will bind to the hormones that are floating around in the blood stream. So once these receptors bind
to a particular hormone, whether it be insulin or glucagon, it actually causes a series of
particular reactions to occur inside of the cell to modify oftentimes enzymes that are
involved in metabolic pathways. So I'll just abbreviate
that with the letter E. And these modifying reactions
that occur in the cell are oftentimes phosphorylation
reactions, that is, either the gain or the
loss of a phosphate group oftentimes on an enzyme
in a metabolic pathway. And so with that in mind,
you can appreciate how modification by
phosphorylation is a lot faster than starting with a DNA
transcript and then going to mRNA and then translating into enzymes, but it is indeed a bit slower
than the second-to-second Le Chatelier and allosteric regulation that can occur in a cell as well.
